mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
about
Immunological hurdles of ageing: indispensable research of the human model.Fasting levels of hepatic p-S6 are increased in old miceEfficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study.Targeting Inflammation and Downstream Protein Metabolism in Sarcopenia: A Brief Up-Dated Description of Concurrent Exercise and Leucine-Based Multimodal Intervention.
P2860
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
@en
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
@nl
type
label
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
@en
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
@nl
prefLabel
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
@en
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia.
@nl
P356
P1476
mTOR signaling as a target of amino acid treatment of the age-related sarcopenia
@en
P2093
Enzo Nisoli
P304
P356
10.1159/000319998
P577
2010-08-10T00:00:00Z